Kirin Holdings, shiseido company,limited sponsored adr, Tokyo Metro, NTT (7 days)
※The above calendar is only a schedule and may be subject to change due to company's convenience. ---------------------------------------November 7th (Thu) <1375> Yukiguni Maitake <1382> Hobe <1439> Yasue Construction <147A> Soracom <1515> Nittetsu-ko <1719> Ando Hazama <1720> Tokyu Construction <1738> NITTOH <1788
KDDI announces a 2.3% increase in operating profit in the second quarter to 573 billion yen, along with a share buyback and split.
KDDI<9433> announced its financial results for the second quarter of the fiscal year ending March 2025, with revenue increasing by 2.8% year-on-year to 2 trillion 855.7 billion 13 million yen, and operating profit increasing by 2.3% to 573 billion 86 million yen. The non-communications sectors such as enterprise digital transformation (DX) support services and finance performed well. The financial estimates for the fiscal year ending in March 2025 remain unchanged. Additionally, up to 100 billion yen, equivalent to 1.39% of the total number of issued shares (excluding treasury stock), is 2800.
List of conversion stocks (Part 3) [List of parabolic signal conversion stocks]
○ List of buy conversion stocks Market Code Stock name Closing price SAR TSE main board <7130> Yamae Group HD 1969 1808 <7239> Tachies 1774 1726 <7246> Press Works 5545 3939 <7272> Yamaha 1354 1281 <7280> Mitsuba 8838 837 <7388> FP Partner 2955 2608 <7419> Nojima 2150 1953 <7447> Nagailebe 229
Asahi Kasei, TDK, Mitsui Chemicals, kddi corporation (1st day)
※Please note that the above calendar is subject to change depending on the company's circumstances.---------------------------------------November 1st (Friday)<2229>Calbee <2282>Nippon Ham<2296>Itoham Yonekyu Holdings <2349>NIID <2440>Gurunavi <2480>Sysmex<2551>MarsaInc <2730>Edion<27
Canon Inc-spons adr, 3Q operating profit increased by 14.4% to 296.6 billion yen.
Canon Inc-Spons ADR <7751> announced its third quarter financial results for the fiscal year ending December 2024, with revenue increasing by 7.3% year-on-year to 3 trillion 236.1 billion 11 million yen, operating profit increasing by 14.4% to 296.6 billion 38 million yen. The gross profit margin increased by 0.8 points from the same period last year to 47.8%, due to cost reductions and favorable product mix, with gross profit also increasing by 7.1% year-on-year to 516.4 billion yen. [Positive evaluation] Takeda Pharmaceuticals Mid-Term <4502> | <7735> S
List of conversion stocks [List of conversion stocks for parabolic signals]
○ List of stocks for buying conversion market Code Name of the stock Closing price SAR Tokyo main board <1786> Oriental Shirashi 379 368 <1814> Daiueken 16351548 <1873> Japan House HD 338328 <1878> Daito Construction 1678016300 <2108> Beet sugar 25792513 <2150> Carenet 674620 <2585> Life Drink C 17641659 <2692> Itochu